Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis

被引:171
作者
Bellido, M. [1 ]
Lugo, L. [1 ]
Roman-Blas, J. A. [1 ]
Castaneda, S. [1 ,2 ]
Calvo, E. [3 ]
Largo, R. [1 ]
Herrero-Beaumont, G. [1 ]
机构
[1] Univ Autonoma Madrid, Bone & Joint Res Unit, Serv Rheumatol, IIS Fdn Jimenez Diaz, Madrid, Spain
[2] Univ Autonoma Madrid, IIS Princesa, Hosp Princesa, Dept Rheumatol, Madrid, Spain
[3] Univ Autonoma Madrid, Dept Orthopaed Surg, IIS Fdn Jimenez Diaz, Madrid, Spain
关键词
Osteoarthritis; Osteoporosis; Cartilage damage; Subchondral bone impairment; PTH [1-34; CRUCIATE LIGAMENT TRANSECTION; KAPPA-B LIGAND; KNEE OSTEOARTHRITIS; ARTICULAR-CARTILAGE; PARATHYROID-HORMONE; MINERAL DENSITY; TREATING OSTEOARTHRITIS; ANTIINFLAMMATORY DRUGS; ESTROGEN DEFICIENCY; RECEPTOR ACTIVATOR;
D O I
10.1016/j.joca.2011.07.003
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Purpose: Impairment of subchondral bone density and quality aggravates cartilage damage in osteoarthritis (OA). Accordingly, we assessed whether improving microstructure and quality at subchondral bone by the bone-forming agent parathyroid hormone (PTH) [1-34] prevent cartilage damage progression in a rabbit model of OA preceded by osteoporosis (OP). Methods: OP was induced in 20 female rabbits. At week 7, these rabbits underwent knee surgery to induce OA and, at week 12, they started either saline vehicle (n = 10) or PTH (n = 10) for 10 weeks. Ten healthy animals were used as controls. At week 22, microstructure was assessed by micro-computed tomography and bone remodelling by protein expression of alkaline phosphatase (ALP), metalloproteinase-9 (MMP9), osteoprotegerin (OPG) and receptor activator of nuclear factor-kappa B ligand (RANKL) at subchondral bone. Cartilage damage was evaluated using Mankin score. Results: PTH reversed the decrease of bone area/tissue area, trabecular thickness, plate thickness, polar moment of inertia, ALP expression and OPG/RANKL ratio, as well as counteracted the increase of fractal dimension and MMP9 expression at subchondral bone of osteoarthritis preceded by osteoporosis (OPOA) rabbits compared to vehicle administration (P < 0.05). Likewise, PTH decreased cartilage damage severity in OPOA rabbits. Good correlations were observed between subchondral bone structure or remodelling parameters, and cartilage Mankin score. Conclusions: Improvement of microstructural and remodelling parameters at subchondral bone by PTH [1-34] contributed to prevent cartilage damage progression in rabbits with early OPOA. These findings support the role of subchondral bone in OA. Further studies are warranted to establish the place of bone-forming agents as potential treatment in OA. (C) 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1228 / 1236
页数:9
相关论文
共 66 条
[1]
AN HS, 1992, SYNOPSIS ORTHOPAEDIC, P491
[2]
Fundamental subchondral bone changes in spontaneous knee osteoarthritis [J].
Anderson-MacKenzie, JM ;
Quasnichka, HL ;
Starr, RL ;
Lewis, EJ ;
Billingham, MEJ ;
Bailey, AJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (01) :224-236
[3]
BARRENA EG, 2004, ANN RHEM DIS, V63, P917
[4]
Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency [J].
Behets, C ;
Williams, JM ;
Chappard, D ;
Devogelaer, JP ;
Manicourt, DH .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (11) :1821-1826
[5]
Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis [J].
Bellido, Miriam ;
Lugo, Laura ;
Roman-Blas, Jorge A. ;
Castaneda, Santos ;
Caeiro, Jose R. ;
Dapia, Sonia ;
Calvo, Emilio ;
Largo, Raquel ;
Herrero-Beaumont, Gabriel .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)
[6]
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis [J].
Bellido, T ;
Ali, AA ;
Gubrij, I ;
Plotkin, LI ;
Fu, Q ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
ENDOCRINOLOGY, 2005, 146 (11) :4577-4583
[7]
Evidence for increased bone resorption in patients with progressive knee osteoarthritis - Longitudinal results from the Chingford study [J].
Bettica, P ;
Cline, G ;
Hart, DJ ;
Meyer, J ;
Spector, TD .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3178-3184
[8]
Novel targets in bone and cartilage [J].
Beyer, Christian ;
Schett, Georg .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2010, 24 (04) :489-496
[9]
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee - Results of the two-year multinational knee osteoarthritis structural arthritis study [J].
Bingham, Clifton O., III ;
Buckland-Wright, J. Chris ;
Garnero, Patrick ;
Cohen, Stanley B. ;
DougadoS, Maxime ;
Adarni, Silvano ;
Clauw, Daniel J. ;
Spector, Timothy D. ;
Pelletier, Jean-Pierre ;
Raynauld, Jean-Pierre ;
Strand, Vibeke ;
Simon, Lee S. ;
Meyer, Joan M. ;
Cline, Gary A. ;
Beary, John F. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (11) :3494-3507
[10]
Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans [J].
Bobinac, D ;
Spanjol, J ;
Zoricic, S ;
Maric, I .
BONE, 2003, 32 (03) :284-290